HealthTech: Hip surgery robot to researching psychedelic drugs
- WARSAW, IN—Zimmer Biomet has received FDA clearance for its total hip replacement system (ROSA surgical robot). ROSA Hip is designed to adapt to a surgeon’s existing workflow by directing preparation, positioning and intra-operatively quantifying cup orientation, leg length and offset.
- MADISON, WI—The University of Wisconsin-Madison has started a new research center that will focus its research on psychedelic drugs. The Transdisciplinary Center for Research in Psychoactive Substances will expand the scope and reach of psychedelic research that started on campus in 2014.
- ST. LOUIS, MO—The EPA awarded a $744,262 grant to Tae Seok Moon, associate professor at the McKelvey School of Engineering, for biotechnology research. Moon’s lab has been working on a “kill switch” for engineered organisms that will self-destruct after completing a specified task, such as cleaning up a pollutant or rooting out and destroying a pathogen in livestock.
- RALEIGH, NC—San Francisco-based Verily will be acquiring SignalPath, a privately held company based in Raleigh that has developed a clinical trial management system (CTMS) that improves the quality and efficiency of conducting clinical research at study sites.